Andrographis paniculata: A review of aspects of regulatory mechanisms of hepatic CYP1A enzymes;Andrographis paniculada: Una revisión de los aspectos de los mecanismos reguladores de las enzimas hepáticas CYP1A

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas

Volumn 7, Issue 2, 2008, Pages 100-107

  Jarukamjorn, Kanokwan ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

AhR; Andrographis paniculata; Andrographolide; CYP1A1; CYP1A2; CYP1B1; EROD; MROD; P450; PROD; UGT1A6

Indexed keywords

ANDROGRAPHAN; ANDROGRAPHIS PANICULATA EXTRACT; ANDROGRAPHOLIDE; ANDROGRAPHOSTERIN; AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 1A2; DEHYDROANDROGRAPHOLIDE; DEOXYANDROGRAPHOLIDE; DITERPENOID; DRUG METABOLITE; ECHINACEA ANGUSTIFLORA EXTRACT; ETHOXYRESORUFIN; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HOMOANDROGRAPHOLIDE; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; LIVER ENZYME; METHOXYRESORUFIN; NEOANDROGRAPHOLIDE; PARACETAMOL; PENTOXYRESORUFIN; RESVERATROL; SABAL EXTRACT; STIGMASTEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANDROGRAPHIS PANICULATA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DETOXIFICATION; DRUG ABSORPTION; DRUG METABOLISM; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; FEVER; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; INFLAMMATION; JAUNDICE; LIVER DISEASE; NONHUMAN; PHYTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 77955529919     PISSN: None     EISSN: 07177917     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Akbarsha MA, Murugaian P. 2000. Aspects of the male reproductive toxicity/male antifertility property of andrographolide in albino rats: Effect on the testis and the cauda epididymidal spermatozoa. Phytother Res 14:432-435.
2. Ander MW. 1985. Bioactivation of Foreign Compounds. New York: Academic Press.
3. Brake PB, Arai M, As-Sanie S, Jefcoate CR. 1999. Widmaier EP. Development expression and regulation of adrenocortical cytochrome P4501B1 in the rat. Endocrinology 140:1672-1680.
4. Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT. 1994. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 30:923-936.
5. Caceres DD, Hancke JL, Burgos RA, Wikman GK. 1997. Prevention of common colds with Andrographis paniculata dried extract: A pilot double-blind trial. Phytomedicine 4:101-104.
6. Calabrese C, Merman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, Standish LJ. 2000. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 14:333-338.
7. Caldwell J, Jakoby WB. 1983. Biological Basis for Detoxification. New York: Academic Press.
8. Cava MP, Chan WR, Stein RP, Willist CR. 1965. Andrographolide. Tetrahedron 21:2617-2632.
9. Chem W, Liang X. 1982. Deoxyandrographolide 19β-Dglucoside from the leaves of Andrographis paniculata. Planta Med 15:245-246.
10. Chiou W, Chen C, Lin J. 2000. Mechanism of suppression of inducible nitric oxide synthase (iNOS) expression in RAW264.7 cells by andrographolide. Br J Pharmacol 129:1553-1560.
11. Chiou W, Lin J, Chen C. 1998. Andrographolide suppressed the expression of inducible nitric oxide synthase in macrophages and restored the vasoconstriction in rat aorta treated with lipopolysaccharide. Br J Pharmacol 125:327-334.
12. Choudhary BR, Poddar MK. 1984. Andrographolide and kalmegh (Andrographis paniculata) extract in vivo and in vitro effect on lipid peroxidation. Meth Find Exp Clin Pharmacol 6:481-485.
13. Chun YJ, Kim MY, Guengerich FP. 1999. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 262:20-24.
14. Conney AH. 1982. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Res 42:4875-4917.
15. Cui L, Qiu F, Yao X. 2005. Isolation and identification of seven glucuronide conjugates of andrographolide in human urine. Drug Metab Dispos 33:555-562.
16. Delgoda R, Westlake ACG. 2004. Herbal interactions involving cytochrome P450 enzymes: a mini review. Toxicol Rev 23:239-249.
17. Deng WL. 1978. Outline of current clinical and pharmacological research on Andrographis paniculata in China. News Chinese Herbal Med 10:27-31.
18. Farrell GC, Murray M. 1990. Human cytochrome P450 isoforms. Their genetic heterogeneity and induction by omeprazole. Gastroenterology 99:885-889.
19. Gastel JA. 2001. Early indicators of response in biologically based risk assessment for nongenotoxic carcinogens. Regul Toxicol Pharmacol 33:393-398.
20. Gelboin HV. 1980. Benzo[a]pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60:1107-1166.
21. Gibson GG, Skett P. 2001. Introduction to Drug Meatbolism. New York: Nelson Thornes Ltd. Gonzalez FJ, Gelboin HV. 1994. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 26:165-183.
22. Guengerich FP, Shimada T. 1998. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res 400:201-213.
23. Guengerich FP. 1988. Role of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 48:2946-2954.
24. Guengerich FP. 2000. Metabolism of chemical carcinogens. Carcinogenesis 21:345-351
25. Handa SS, Sharma A. 1990a. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbon tetrachloride. Indian J Med Res (B) 92:276-283.
26. Handa SS, Sharma A. 1990b. Hepatoprotective activity of andrographolide against galactosamine and paracetamol intoxication in rats. Indian J Med Res (B) 92:284-292.
27. He X, Li JK, Gao H, Qiu F, Hu K, Cui XM, Yao XS. 2003a. Four new andrographolide metabolites in rats. Tetrahedron 59:6603-6607.
28. He X, Li JK, Gao H, Qiu F, Hu K, Cui XM, Yao XS. 2003b. Six new andrographolide metabolites in rats. Chem Pharm Bull 51:586-589.
29. He X, Li JK, Gao H, Qiu F, Hu K, Cui XM, Yao XS. 2003c. Identification of a rare sulfonic acid metabolite of andrographolide in rats. Drug Metab Dispos 31:983-985.
30. Hecht SS. 1999. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194-1210.
31. Honkakoski P, Negishi M. 1997. Regulatory DNA elements of phenobarbital-responsive cytochrome P450 CYP2B genes. J Biochem Mol Toxicol 12:3-9.
32. Iruretagoneya MI, Tobar JA, Gonzalez PA, Sepulveda SE, Figueroa CA, Burgos RA, Hancke JL, Kalergis AM. 2005. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J Pharmacol Exp Ther 312:366-372.
33. Iwanari M, Nakajima M, Kizu R, Hayakawa K, Yokoi T. 2002. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoforms-, and cell-specific differences. Arch Toxicol 76:287-298.
34. Izzo AA, Ernst E. 2001. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61:2163-2175.
35. Jaruchotikamol A, Jarukamjorn K, Sirisangtrakul W, Sakuma T, Kawasaki Y, Nemoto N. 2007. Strong synergistic induction of CYP1A1 expression by andrographolide plus typical CYP1A inducers in mouse hepatocytes. Toxicol Appl Pharm 224:156-162.
36. Jarukamjorn K, Don-in, K., Makejaruskul C, Laha T, Daodee S, Pearaksa P, Sripanidkulchai B. 2006. Impact of Andrographis paniculata crude extract on mouse hepatic cytochrome P450 enzymes. J Ethnopharmacol 105:464-467.
37. Jarukamjorn K, Sakuma T, Miyaura J, Nemoto N. 1999. Different regulation of the expression of mouse hepatic cytochrome P450 2B enzymes by glucocorticoid and phenobarbital. Arch Biochem Biophys 369:89-99.
38. Jerina DM. 1983. The 1982 Bernard B. Brodie Award Lecture. Metabolism of aromatic hydrocarbons by the cytochrome P-450 system and epoxide hydrolase. Drug Metab Dispos 11:1-4.
39. Kapil A, Koul IB, Banerjee SK, Gupta D. 1993. Antihepatotoxic effects of major constituents of Andrographis paniculata. Biochem Pharmacol 46:182-185.
40. Kimura S, Gonzalez FJ, Nebert DW. 1986. Tissue-specific expression of the mouse dioxin-inducible P1450 and P3450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues. Mol Cell Biol 6:1471-1477.
41. Kumar RA, Sridevi K, Kumar NV, Nanduri S, Rajagopal S. 2004. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 92:291-295.
42. Le Corre L, Chalabi N, Delort L, Bignon YJ, BernardGallon DJ. 2006. Differential expression of genes induced by resveratrol in human breast cancer cell lines. Nutr Cancer 56:193-203.
43. Mabic S, Castagnoli K, Castagnoli N. 1999. Oxidative metabolic bioactivation of xenobiotics. In: Woolf TF, editor. Handbook of Drug Metabolism, New York: Marcel Dekker, Inc. pp. 49-79.
44. Madav HC, Tripathi T, Mishra SK. 1995. Analgesic, antipyretic, and antiulcerogenic effects of andrographolide. Indian J Pharm Sci 57:121-125.
45. Meng ZM. 1981. Studies on the structure of the adduct of andrographolide with sodium hydrogen sulfite. Acta Pharmacol Sin 16:571-575.
46. Miller EC, Miller JA. 1981. Mechanisms of chemical carcinogenesis. Cancer 47:1055-1064.
47. Miller RE, Guengerich FP. 1982. Oxidation of trichloroethylene by liver microsomal cytochrome P450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 21:1090-1097.
48. Nanduri A, Nyavanandi VK, Thynuguntla SSR, Kasu A, Pallerla MK, Ram PS, Rajagopal S, Kumar RA, Ramanujam R, Babu JM, Vyas K, Devi AS, Reddy GO, Akella V. 2004. Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents. Bioorg Med Chem Lett 14:4711- 4717.
49. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ. 2004. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847-23850.
50. Nemoto N. Sakurai J. 1992. Differences in regulation of gene expression between Cyp1a-1 and Cyp1a-2 in adult mouse hepatocytes in primary culture. Carcinogenesis 13:2249-2254.
51. Nemoto N, Sakurai J, Tazawa A, Ishikawa T., 1989. Proline-dependent expression of aryl hydrocarbon hydroxylase in C57BL/6 mouse hepatocytes in primary culture. Cancer Res 49:5863-5869.
52. Obach RS. 2000. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 294:88-95.
53. Panossain A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, Goukasova G, Wikman G, Wagner H. 2000. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine 7:351-364.
54. Park CE, Kim MJ, Lee JH, Min BI, Bae H, Choe W, Kim SS, Ha J. 2007. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMPactivated protein kinase. Exp Mol Med 39:222-229.
55. Parkinson A. 1996. Biotransformation of xenobiotics. In: Klaassen CD, editor. Toxicology the Basic Science of Poisons, New York: McGraw-Hill. p. 113.
56. Pelkonen O, Nebert DW. 1982. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 34:189-222.
57. Petry T, Schmid P, Achlatter C. 1996. The use of toxic equivalency factors in assessing occupational and environmental health risk associated with exposure to airborne mixtures of polycyclic aromatic hydrocarbons (PAHs). Chemosphere 32:639-648.
58. Procter RN. 2001. Tobacco and the global lung cancer epidemic. Nat Rev Cancer 1:82-86.
59. Puri A, Saxena R, Saxena RP, Saxena KC, Srivastava V, Tandon JS. 1993. Immunostimulant agents from Andrographis paniculata. J Nat Prod 56:995-999.
60. Ryu DY, Hodgson E. 1999. Constitutive expression and induction of CYP1B1 mRNA in the mouse. J Biochem Mol Toxicol 13:249-251.
61. Sakuma T, Ohtake M, Katsurayama Y, Jarukamjorn K, Nemoto N. 1999. Induction of CYP1A2 by phenobarbital in the livers of aryl hydrocarbonresponsive and -nonresponsive mice. Drug Metab Dispos 27:379-384.
62. Savas U, Bhattacharyya KK, Christou M, Alexander DL, Jecoate CR. 1994. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P450s; cloning, sequence determination and tissue expression. J Biol Chem 269:14905-14911.
63. Shama A, Lal K, Handa SS. 1992. Standardization of Indian crude drug Kalmegh by high pressure liquid chromatographic determination of andrographolide. Phytochem Anal 3:129.
64. Shen YC, Chen CF, Chiou WF. 2002. Andrographolide prevents oxygen radical production by human neutrophils: Possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 135:399-406.
65. Shen YC, Chen CF, Chiou WF. 2000. Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med 66:314-317.
66. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR. 1996. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 56:2979-2984.
67. Shimada T. 2000. Human cytochrome P450 1B1 and chemical carcinogenesis. Rev Toxicol 39:103-125.
68. Shimada T, Inoue K, Suzuki Y, Kawai T, Azuma E, Nakajima T, Shindo M, Kurose K, Sugie A, Yamagishi Y, Fujii-Kuriyama Y, Hashimoto M. 2002. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated buphynyls in genetically engineered C57BL/6J mice. Carcinogenesis 23:1199-1207.
69. Singh RP, Banerjee S, Rao AR. 2001. Modulatory influence of Andrographis paniculata on mouse hepatic and extrahepatic carcinogen metabolizing enzymes and antioxidant status. Phytother Res 15:382-290.
70. Siripong P, Kongkatip B, Prechanukool K, Picha P, Tansuwan K, Taylor WC. 1992. Cytotoxic diterpenoid constitutents from Andrographis paniculata Nees leaves. 18:187-194.
71. Sjogren M, Ehrenberg L, Rannug U. 1996. Relevance of different biological assays in assessing initiating and promoting properties of polycyclic aromatic hydrocarbons with respect to carcinogenic potency. Mutat Res 358:97-112.
72. Strandell J, Neil A, Carlin G. 2004. An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine 11:98-104.
73. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE. 2006. Health benefits of herbs and spices: the past, the present, the future. Med J Aust 21:S4-24.
74. Trivedi N, Rawal UM. 2000. Hepatoprotective and toxicological evaluation of Andrographis paniculata on severe liver damage. Indian J Pharmacol 32:288-293.
75. Uno S, Dalton TP, Derkenne S, Curran CP, Miller ML, Shertzer HG, Nebert DW. 2004. Oral exposure to benso[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol 65:1225-1237.
76. Valles B, Schiler CD, Coassolo P, De Sousa G, Wyss R, Jaeck D, Viger-Chougnet A, Rahmani R. 1995. Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation. Drug Metab Dispos 23:1051-1057.
77. Vermeulen NPE, Donné-Op den Kelder G, Commandeur JNH. 1992. Formation of and protection against toxic reactive intermediates. In: Vermeulen, editor. Perspectives in Medicinal Chemistry, Basel: Helvetical Chimica Acta. p. 253.
78. Vermeulen NPE. 1996. Role in metabolism in chemical toxicity. In: Ioannides C, editor. Cytochrome P450 Metabolic and Toxicological Aspects, New York: CRC Press. pp. 29-53.
79. Wang T, Liu B, Zhang W, Wilson B, Hong JS. 2004. Andrographolide reduces inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronglia cultures by inhibiting microglial activation. J Pharmacol Exp Ther 308:975-983.
80. Whitlock JP. 1999. Induction of cytochrome P4501A1. Ann Rev Pharmacol Toxicol 39:103-125.
81. Williams RT. 1971. Detoxification Mechanisms. 2nd ed. New York: John Wiley & Sons.